Clinical Trials Browser

Phase 2 × OTHER × Artesunate × Clear all

NCT07022743 2025-09-05

Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination Therapy

Phase 2 Active not recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02633098 2022-10-12

NeoART

Phase 2 Unknown

Gastrointestinal

Intestinal Neoplasms, Colorectal Neoplasms